Irvine-based ChromaDex Corp., a maker of ingredients for dietary supplements and other products, signed a four-year, $62 million supply contract with 5Linx Enterprises Inc., a marketing firm in Rochester, N.Y.
5Linx, which had about $104 million in 2012 revenue, has been ranked among the largest direct sales companies in the world by Lake Dallas, Texas-based Direct Selling News.
ChromaDex is expected to sell about $48 million worth of its recently patented compound, Niagen Nicotinamide Riboside, to 5Linx through 2017.
It’s also expected to sell about $14.5 million of Purenergy, a caffeine alternative, over the next four years.
ChromaDex has had increases in both revenues and net losses in recent years.
—Jane Yu
